About the Hemostats and Tissue Sealants Market
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.
Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
Technavio’s analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:
• Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
• Tissue sealants (fibrin and synthetic sealants)
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Advanced Medical Solutions Group
• Baxter International
• C. R. Bard
• Cryolife
• CSL Behring
• Integra LifeSciences
• Johnson & Johnson (Ethicon)
Other prominent vendors
• B. Braun
• Cardinal Health
• Cohera Medical
• Haemacure
• HyperBranch Medical Technology
• NeoMend
• Smith & Nephew
• Teijin Pharma
• Tissuemed
• Vascular Solutions
• Vivostat
• Z-Medica
Market driver
• Focus on patient safety and quicker recovery
• For a full, detailed list, view our report
Market challenge
• Paucity of ready-to-use products
• For a full, detailed list, view our report
Market trend
• Approval of fibrin sealants as broad level hemostats
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Coagulation
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
PART 07: Global hemostats market
PART 08: Global tissue sealants market
PART 09: Geographical segmentation
• Geographical segmentation of global hemostats and tissue sealants market
• Hemostats and tissue sealants market in Americas
• Hemostats and tissue sealants market in EMEA
• Hemostats and tissue sealants market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Advanced Medical Solutions Group
• Baxter International
• C. R. Bard
• CryoLife
• CSL Behring
• Integra LifeSciences
• Johnson & Johnson (Ethicon)
• Other prominent vendors
PART 16: Appendix
PART 17: Explore Technavio
Exhibit 01: Product offerings
Exhibit 02: Process of coagulation
Exhibit 03: Mechanism of blood coagulation
Exhibit 04: Global hemostats and tissue sealants market
Exhibit 05: Global hemostats and tissue sealants market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Segmentation of global hemostats and tissue sealants market by product type
Exhibit 08: Segmentation of global hemostats and tissue sealants market by product type 2015
Exhibit 09: Segmentation of global hemostats and tissue sealants market by product type 2020
Exhibit 10: Segmentation of global hemostats and tissue sealants market by product type 2015-2020
Exhibit 11: Global hemostats market 2015-2020 ($ billions)
Exhibit 12: Segmentation of global hemostats market by type of product 2015
Exhibit 13: Categorization of active hemostats
Exhibit 14: Categorization of mechanical hemostats
Exhibit 15: Categorization of flowable hemostats
Exhibit 17: Global tissue sealants market 2015-2020 ($ billions)
Exhibit 18: Segmentation of global tissue sealants market by type 2015
Exhibit 19: Categorization of fibrin sealants
Exhibit 20: Categorization of synthetic sealants
Exhibit 21: Segmentation of global hemostats and tissue sealants market by geography 2015
Exhibit 22: Segmentation of global hemostats and tissue sealants market by geography 2020
Exhibit 23: Segmentation of global hemostats and tissue sealants market by geography 2015-2020
Exhibit 24: Hemostats and tissue sealants market in Americas 2015-2020 ($ billions)
Exhibit 25: Hemostats and tissue sealants market in EMEA 2015-2020 ($ billions)
Exhibit 26: Segmentation of hemostats and tissue sealants market in Europe 2015
Exhibit 27: Hemostats and tissue sealants market in APAC 2015-2020 ($ millions)
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Ranking of vendors in global hemostats market 2015
Exhibit 31: Ranking of vendors in global tissue sealants market 2015
Exhibit 32: Advanced Medical Solutions Group: Product portfolio
Exhibit 33: Advanced Medical Solutions Group: Branded Direct segment by revenue 2013-2015 ($ millions)
Exhibit 34: Advanced Medical Solutions Group: Key takeaways
Exhibit 35: Baxter International: Key takeaways
Exhibit 36: Product group category
Exhibit 37: C. R. Bard: Product portfolio
Exhibit 38: C.R. Bard: Surgical specialty product segment by revenue 2013-2015 ($ millions)
Exhibit 39: C. R. Bard: Key takeaways
Exhibit 40: CryoLife: Key takeaways
Exhibit 41: CSL Behring: Key takeaways
Exhibit 42: Imtegra LifeSciences: Product segmentation
Exhibit 43: Integra LifeSciences: Product portfolio
Exhibit 44: Integra LifeSciences: Orthopedics and tissue technologies segment by revenue 2013-2015 ($ millions)
Exhibit 45: Integra LifeSciences :Key takeaways
Exhibit 46: Johnson & Johnson (Ethicon): Key takeaways
Exhibit 47: Other prominent vendors
